Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1050 U.S. listed China Stocks and Counting...
 Tracking 1535 U.S. Stocks and Counting...

 Bohai Pharmaceuticals (OTC BB:BOPH)

Tuesday, January 12, 2010

Yantai Bohai Pharmaceuticals Group Co., Ltd. went public via a share exchange on January 5, with Link Resources.

Highlights:

  • Bohai is a profitable company principally engaged in the production, manufacturing and distribution of herbal pharmaceuticals based on traditional Chinese medicine in China.
  • Bohai’s medicines address common health problems such as rheumatism, rheumatoid arthritis, respiratory diseases, viral infections, gynecological diseases and cardio vascular issues.
  • Bohai’s products are sold either by prescription through hospitals or Over the Counter through local pharmacies and retail drug store chains.
  • Bohai generated approximately $50.2 million in audited revenues and approximately $8.0 million in audited net earnings for the fiscal year ended June 30, 2009

Source: Business Wire (January 5, 2010)